Santen Pharmaceutical Co (JP:4536) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Santen Pharmaceutical Co. has announced the cancellation of 16,985,400 treasury shares, representing 4.7% of its outstanding shares, with the action set to be completed by November 29, 2024. This strategic move is expected to leave the company with 347,036,854 outstanding shares, streamlining its share structure.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.